These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3123614)

  • 21. Leflunomide for rheumatoid arthritis.
    Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Z Rheumatol; 2004 Feb; 63(1):59-75. PubMed ID: 14991279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparities in care by insurance status for individuals with rheumatoid arthritis: analysis of the medical expenditure panel survey, 2006-2009.
    Cifaldi M; Renaud J; Ganguli A; Halpern MT
    Curr Med Res Opin; 2016 Dec; 32(12):2029-2037. PubMed ID: 27551731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of drug and administrative costs allowed by U.S. Private and public third-party payers for 3 intravenous biologic agents for rheumatoid arthritis.
    Wong BJ; Cifaldi MA; Roy S; Skonieczny DC; Stavrakas S
    J Manag Care Pharm; 2011 May; 17(4):313-20. PubMed ID: 21534642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Runaway Costs in Medi-Cal-a myth.
    Heckman JR; Jones MW
    West J Med; 1980 Jun; 132(6):562-6. PubMed ID: 6996335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer stage at diagnosis in relation to duration of medicaid enrollment.
    Perkins CI; Wright WE; Allen M; Samuels SJ; Romano PS
    Med Care; 2001 Nov; 39(11):1224-33. PubMed ID: 11606876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of very early rheumatoid arthritis with symptomatic therapy, disease-modifying antirheumatic drugs, or biologic agents: a cost-effectiveness analysis.
    Finckh A; Bansback N; Marra CA; Anis AH; Michaud K; Lubin S; White M; Sizto S; Liang MH
    Ann Intern Med; 2009 Nov; 151(9):612-21. PubMed ID: 19884622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis.
    Oladapo A; Barner JC; Lawson KA; Novak S; Rascati KL; Richards KM; Harrison DJ
    J Manag Care Spec Pharm; 2014 Jul; 20(7):657-67. PubMed ID: 24967519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coordination of health coverage for Medicare enrollees: living with HIV/AIDS in California.
    Eichner J; Kahn JG
    Medicare Brief; 2001 Aug; (8):1-10. PubMed ID: 11797740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Maetzel A; Strand V; Tugwell P; Wells G; Bombardier C
    Arthritis Rheum; 2002 Dec; 47(6):655-61. PubMed ID: 12522841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competing for Medi-Cal business: why hospitals did, and did not, get contracts.
    Brown ER; Cousineau MR; Price WT
    Inquiry; 1985; 22(3):237-50. PubMed ID: 2931367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The long-term effects of Medicaid managed care on obstetrics care in three California counties.
    Tai-Seale M; LoSasso AT; Freund DA; Gerber SE
    Health Serv Res; 2001 Aug; 36(4):751-71. PubMed ID: 11508638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis.
    Kim G; Barner JC; Rascati K; Richards K
    Clin Ther; 2016 Mar; 38(3):646-54. PubMed ID: 26899313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repackaged pharmaceuticals in the California workers' compensation system: from distribution and pricing options to physician and retail dispensing.
    Gitlin M; Wilson L
    Am J Ind Med; 2007 Apr; 50(4):303-15. PubMed ID: 17370319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of introducing biologics to patients with rheumatoid arthritis in Taiwan: a population-based trend study.
    Lang HC; Lee HC; Lee SS; Lin HY; Chiu YM
    Int J Rheum Dis; 2016 Nov; 19(11):1112-1118. PubMed ID: 26890537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rise in Medi-Cal Enrollment Corresponded to Increases in California County Health Spending During ACA Implementation.
    Charles SA; Nepomuceno, F; Kominski GF
    Policy Brief UCLA Cent Health Policy Res; 2018 Sep; 2018(6):1-8. PubMed ID: 30272906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.
    Schädlich PK; Zeidler H; Zink A; Gromnica-Ihle E; Schneider M; Straub C; Brecht JG; Huppertz E
    Pharmacoeconomics; 2005; 23(4):377-93. PubMed ID: 15853437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.
    Blomqvist P; Feltelius N; Ekbom A; Klareskog L
    J Rheumatol; 2000 May; 27(5):1171-7. PubMed ID: 10813283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatologic care of nursing home residents with rheumatoid arthritis: a comparison of the year before and after nursing home admission.
    Luque Ramos A; Albrecht K; Zink A; Hoffmann F
    Rheumatol Int; 2017 Dec; 37(12):2059-2064. PubMed ID: 28821941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of β-d-mannuronic acid, as a novel non-steroidal anti-inflammatory medication within immunosuppressive properties, on
    Barati A; Jamshidi AR; Ahmadi H; Aghazadeh Z; Mirshafiey A
    Drug Des Devel Ther; 2017; 11():1027-1033. PubMed ID: 28408801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.